MX2014011484A - Metodo para seguir las respuestas de celulas t especificas al vih. - Google Patents
Metodo para seguir las respuestas de celulas t especificas al vih.Info
- Publication number
- MX2014011484A MX2014011484A MX2014011484A MX2014011484A MX2014011484A MX 2014011484 A MX2014011484 A MX 2014011484A MX 2014011484 A MX2014011484 A MX 2014011484A MX 2014011484 A MX2014011484 A MX 2014011484A MX 2014011484 A MX2014011484 A MX 2014011484A
- Authority
- MX
- Mexico
- Prior art keywords
- cell responses
- hiv specific
- monitoring hiv
- monitoring
- hiv
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000005867 T cell response Effects 0.000 title abstract 3
- 238000012544 monitoring process Methods 0.000 title abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 2
- 108090000695 Cytokines Proteins 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 239000012636 effector Substances 0.000 abstract 1
- 238000000684 flow cytometry Methods 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000012289 standard assay Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- AIDS & HIV (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615038P | 2012-03-23 | 2012-03-23 | |
| EP12382109 | 2012-03-23 | ||
| PCT/EP2013/056110 WO2013139972A1 (en) | 2012-03-23 | 2013-03-22 | Method for monitoring hiv specific t cell responses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2014011484A true MX2014011484A (es) | 2015-09-23 |
Family
ID=49221879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014011484A MX2014011484A (es) | 2012-03-23 | 2013-03-22 | Metodo para seguir las respuestas de celulas t especificas al vih. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9709577B2 (enExample) |
| EP (1) | EP2828656B1 (enExample) |
| JP (1) | JP6272820B2 (enExample) |
| CN (1) | CN104272108A (enExample) |
| CA (1) | CA2868066C (enExample) |
| HK (1) | HK1205264A1 (enExample) |
| IN (1) | IN2014DN08394A (enExample) |
| MX (1) | MX2014011484A (enExample) |
| WO (1) | WO2013139972A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101777256B1 (ko) | 2016-07-07 | 2017-09-12 | 대한민국(농림축산식품부 농림축산검역본부장) | T 세포의 병원체 감염 세포 독성능 평가 방법 |
| KR101777252B1 (ko) | 2016-07-07 | 2017-09-12 | 대한민국(농림축산식품부 농림축산검역본부장) | T 세포의 prrsv 증식 억제능 평가 방법 |
| CN110308285B (zh) * | 2019-07-12 | 2022-07-26 | 中国人民解放军军事科学院军事医学研究院 | 用于预测重度电离辐射损伤死亡的标志物组合 |
| CA3255609A1 (en) * | 2022-03-09 | 2023-09-14 | Institucio Catalana De Recerca I Estudis Avanqats | AMPLIFIED IMMUNE MONITORING METHODS FOR ANALYZING ANTIGEN-SPECIFIC T LYMPHOCYTE RESPONSES |
| CN115754303A (zh) * | 2022-11-24 | 2023-03-07 | 复旦大学附属华山医院 | 基于Th1和Th2细胞因子组合的评价方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624456D0 (en) * | 1996-11-25 | 1997-01-15 | Isis Innovation | Assay method |
| HK1044040A1 (zh) * | 1998-11-16 | 2002-10-04 | 德克萨斯州立大学董事会 | Hiv-特异的t-细胞诱导 |
| AU2002952548A0 (en) * | 2002-11-08 | 2002-11-21 | Cellestis Limited | Diagnostic assay |
| WO2005017192A2 (en) * | 2003-08-14 | 2005-02-24 | The General Hospital Corporation | Screening for gestational disorders |
| EP1767937A1 (en) * | 2005-09-27 | 2007-03-28 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method of diagnosis of tuberculosis related immune restoration syndrome (IRS) |
| ATE476656T1 (de) * | 2006-03-20 | 2010-08-15 | St Vincents Hosp Sydney | Verfahren zum nachweis antigenspezifischer oder mitogenaktivierter t-zellen |
| WO2008127840A2 (en) * | 2007-03-22 | 2008-10-23 | University Of Iowa Research Foundation | Flavivirus ns5a proteins for the treatment of hiv |
| US20090263828A1 (en) * | 2008-04-16 | 2009-10-22 | Franco Lori | Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay) |
| WO2010037408A1 (en) * | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| KR20140041505A (ko) * | 2011-04-29 | 2014-04-04 | 셀렉타 바이오사이언시즈, 인크. | 조절 b 세포 유도를 위한 관용원성 합성 나노운반체 |
-
2013
- 2013-03-22 IN IN8394DEN2014 patent/IN2014DN08394A/en unknown
- 2013-03-22 JP JP2015502244A patent/JP6272820B2/ja active Active
- 2013-03-22 US US14/386,940 patent/US9709577B2/en active Active
- 2013-03-22 MX MX2014011484A patent/MX2014011484A/es unknown
- 2013-03-22 HK HK15105947.6A patent/HK1205264A1/xx unknown
- 2013-03-22 CA CA2868066A patent/CA2868066C/en active Active
- 2013-03-22 WO PCT/EP2013/056110 patent/WO2013139972A1/en not_active Ceased
- 2013-03-22 CN CN201380022862.8A patent/CN104272108A/zh active Pending
- 2013-03-22 EP EP13711681.0A patent/EP2828656B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1205264A1 (en) | 2015-12-11 |
| EP2828656A1 (en) | 2015-01-28 |
| CA2868066C (en) | 2019-11-12 |
| WO2013139972A1 (en) | 2013-09-26 |
| CN104272108A (zh) | 2015-01-07 |
| US20150057175A1 (en) | 2015-02-26 |
| IN2014DN08394A (enExample) | 2015-05-08 |
| JP2015513100A (ja) | 2015-04-30 |
| CA2868066A1 (en) | 2013-09-26 |
| EP2828656B1 (en) | 2019-09-18 |
| JP6272820B2 (ja) | 2018-01-31 |
| US9709577B2 (en) | 2017-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018004206A (es) | Metodos para diagnosticar enfermedades infecciosas utilizando medios de adsorcion. | |
| IN2014DN08394A (enExample) | ||
| WO2015114506A3 (en) | Biosensors for the detection of infection and associated maladies | |
| MY194887A (en) | Device and System for Analyzing a Sample, Particularly Blood, as Well as Methods of Using The Same | |
| WO2012024194A3 (en) | Microfluidic cell separation in the assay of blood | |
| EP2825298A4 (en) | MIXTURES OF SULFONED BLOCK COPOLYMERS AND PARTICLE CARBON AND MEMBRANES, FILMS AND COATINGS THEREWITH | |
| EP4410315A3 (en) | Anti-cd3 antibodies and methods of use | |
| EP2775162A3 (en) | Composite bead plate and an air spring using the same | |
| EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
| WO2015175301A8 (en) | Flexible, integrated urine-based diagnostic device | |
| IN2015DN01760A (enExample) | ||
| CY1120220T1 (el) | Μεθοδοι και κυτια για προσδιορισμο της καταστασης λοιμωξης απο φυματιωση | |
| EP2927046A3 (en) | Protection system against reverse battery connection | |
| EP2557407A3 (en) | Pressure sensor | |
| EP3293254A3 (en) | Point of care assays to detect the status of tuberculosis infection | |
| WO2018162740A3 (en) | Cell culture supplements | |
| WO2016069612A3 (en) | Biomarkers for early diagnosis and differentiation of mycobacterial infection | |
| WO2016029094A8 (en) | Specimen conditioning and imaging system | |
| WO2014153661A8 (en) | Method for detecting and monitoring bone loss | |
| EP2623842A3 (en) | Clamp seal | |
| WO2015061610A3 (en) | Human t cell line assay for evaluating the immunologic identity of glatiramer acetate preparations | |
| RU2011153126A (ru) | Способ видовой идентификации микобактерий туберкулеза у лиц, инфицированных микобактериями туберкулеза | |
| WO2016168741A3 (en) | Detection of human cytomegalovirus | |
| WO2013132344A3 (en) | Split-sensor dielectrophoretic/magnetophoretic cytometer | |
| RU2014152102A (ru) | Способ оценки состояния здоровья человека при прогнозировании течения инфекционного заболевания |